Fate's close­ly watched stem cell-de­rived NK pro­gram rais­es red flag over dura­bil­i­ty of re­sponse

4 years ago
R&D
Cell/Gene Tx

J&J's Alex Gorsky set to step away from CEO role, hand­ing the reins to Covid-19 czar Joaquin Du­a­to

4 years ago
People
Pharma

Covid-19 man­u­fac­tur­ing roundup: Sene­gal looks to get in the man­u­fac­tur­ing mix; As­pen vac­cine ex­ports part of ...

4 years ago
R&D
Manufacturing

As Cu­ria ex­pands, it will add API site in up­state New York; In bat­tle against food al­ler­gies, Al­ladapt to build site ...

4 years ago
R&D
Manufacturing

Mov­ing be­yond just sol­id dose, Re­cro Phar­ma is head­ed to San Diego with ac­qui­si­tion

4 years ago
R&D

FDA blasts In­di­an man­u­fac­tur­er's MD site for un­clean con­di­tions in Form 483 let­ter

4 years ago
Manufacturing

Philip Mor­ris nabs over 20% of Vec­tura's shares; On­copep­tides drug may be head­ed for ad­comm, CEO says

4 years ago
News Briefing

J&J hunts for a Ry­bre­vant la­bel add just months af­ter rare lung can­cer ap­proval

4 years ago
R&D

UK's cost-ef­fec­tive­ness gate­keep­er wants to pro­vide faster ac­cess to more new drugs

4 years ago
R&D
Pharma

Chi­na's Abo­gen, a small mR­NA up­start, sets a biotech record with mam­moth $700M Se­ries C

4 years ago
Financing
China

Covid-19 roundup: Pfiz­er vac­cine's ef­fec­tive­ness de­clines faster than As­traZeneca, UK study finds; What about J&J ...

4 years ago
Coronavirus

As de­mand for vac­cines grow, an Al­aba­ma vial mak­er lands an­oth­er fed­er­al con­tract

4 years ago
Coronavirus
Manufacturing

Re­call re­port: More Chan­tix lots pulled from shelves as ni­trosamine woes con­tin­ue

4 years ago
Manufacturing

CSL's Se­qirus, spurred on by Covid-19 mR­NA vac­cines, props up new unit for 'self-am­pli­fy­ing' shot tech

4 years ago
Pharma

The heart fail­ure mar­ket gets a lit­tle more crowd­ed, as Eli Lil­ly and Boehringer In­gel­heim score a win for Jar­diance

4 years ago
FDA+

What an­titrust chal­lenge? Il­lu­mi­na com­pletes $8B Grail buy­out while FTC, EU probes re­main on­go­ing

4 years ago
Deals
Pharma

Jun­shi, Co­herus gun for ma­jor PD-(L)1 mar­ket with PhI­II NSCLC re­sults

4 years ago
China

We asked our bio­phar­ma read­ers about their com­pa­ny's poli­cies on vac­cine man­dates. Feel­ings are run­ning strong

4 years ago
Startups
Pharma

An­oth­er con­va­les­cent plas­ma tri­al for Covid-19 goes bust, but some ex­perts are still hold­ing out hope

4 years ago
Coronavirus

FDA+ roundup: New un­ti­tled let­ter for web ads with­out risk in­fo; PAN­DAs and reg­u­la­to­ry un­cer­tain­ty

4 years ago
FDA+

Sesen Bio tri­al marred by mis­con­duct — re­port; Bris­tol My­ers picks up de­vel­op­ment of AI out­fit's im­munol­o­gy drug

4 years ago
News Briefing

A transpa­cif­ic biotech rush­es to­ward the clin­ic with a twist on clas­sic pro­tein de­graders

4 years ago
Financing

Covid-19 vac­cine boost­er shots to kick off for gen­er­al pop­u­la­tion in one month, NIH, CDC and FDA say in joint ...

4 years ago
Coronavirus

Biotech co-founder set­tles ma­jor re­search mis­con­duct al­le­ga­tions with HHS

4 years ago
People
First page Previous page 649650651652653654655 Next page Last page
A service from the Financial Times